Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 13 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PULSE BIOSCIENCES, INC. | 24,134 | reported | 15 Aug 2025 | tx 22+752,686−309,653 |
| Summit Therapeutics Inc. | 11,232 | reported | 02 Jan 2026 | tx 36+97,164,172−1,195,721 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Summit Therapeutics Inc. | 11,232 | 8.76 USD | deriv |
| 21 Oct 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 266,808 | 18.74 USD | |
| 21 Oct 2025 | PURCHASE | Summit Therapeutics Inc. | 26,680 | 18.74 USD | |
| 21 Oct 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 13,980,789 | 18.74 USD | |
| 10 Sept 2025 | PURCHASE | Summit Therapeutics Inc. | 333,394 | 17.68 USD | first after silence |
| 11 Sept 2025 | PURCHASE | Summit Therapeutics Inc. | 5,000 | 18.07 USD | |
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 30,000 | 0.00 USD | deriv |
| 15 Aug 2025 | GRANT_AWARD | PULSE BIOSCIENCES, INC. | 24,134 | 0.00 USD | deriv |
| 30 May 2025 | EXERCISE | Summit Therapeutics Inc. | 74,545 | 2.64 USD | |
| 30 May 2025 | EXERCISE | Summit Therapeutics Inc. | 74,545 | 0.00 USD | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 9,590,558 | — | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 1,040,000 | — | deriv |
| 29 Apr 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 400,000 | — | deriv |
| 08 Apr 2025 | EXERCISE | Summit Therapeutics Inc. | 3,985,055 | 1.58 USD | |
| 08 Apr 2025 | EXERCISE | Summit Therapeutics Inc. | 3,985,055 | 0.00 USD | deriv |
| 24 Jan 2025 | EXERCISE | PULSE BIOSCIENCES, INC. | 30,121 | 11.00 USD | |
| 03 Feb 2025 | EXERCISE | PULSE BIOSCIENCES, INC. | 30,121 | 11.00 USD | |
| 03 Feb 2025 | EXERCISE | PULSE BIOSCIENCES, INC. | 30,121 | 0.00 USD | deriv |
| 24 Jan 2025 | EXERCISE | PULSE BIOSCIENCES, INC. | 30,121 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Summit Therapeutics Inc. | 10,724 | 9.18 USD | deriv |
| 03 Oct 2024 | EXERCISE | Summit Therapeutics Inc. | 315,681 | 1.58 USD | |
| 03 Oct 2024 | EXERCISE | Summit Therapeutics Inc. | 315,681 | 0.00 USD | deriv |
| 11 Sept 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 44,052 | 22.70 USD | |
| 23 Aug 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 100,000 | — | deriv |
| 23 Aug 2024 | GRANT_AWARD | Summit Therapeutics Inc. | 2,397,640 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 10 Sept 2025.